Pfizer launches Phase III trial for Lyme disease vaccine
Drug Discovery World
AUGUST 12, 2022
Pfizer has launched a Phase III clinical trial of a vaccine to protect people against Lyme disease, in collaboration with pharmaceutical company Valneva. . VLA15 is the only Lyme disease vaccine candidate currently in clinical development. Official comments .
Let's personalize your content